Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-10

Clinical Trial Update: Norwegian Constraint-Induced (CI) Therapy Multisite Trial [Phase 3]

View source ↗

Summary

A Phase 3 multi-site trial evaluating Constraint-Induced Therapy for cerebrovascular accident (stroke) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital of North Norway | Conditions: Cerebrovascular Accident | Phase 3 | Status: TERMINATED